{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:21:22Z","timestamp":1785885682805,"version":"3.56.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Anhui Provincial Major and Difficult Diseases Collaborative Chinese and Western Medicine Project","award":["No. 0708-2021"],"award-info":[{"award-number":["No. 0708-2021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13394-0","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T10:10:53Z","timestamp":1736503853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A novel nomogram for predicting the morbidity of chronic atrophic gastritis based on serum CXCL5 levels"],"prefix":"10.1186","volume":"25","author":[{"given":"Bei","family":"Pei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kairui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"13394_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209\u201349.","journal-title":"Cancer J Clin"},{"key":"13394_CR2","doi-asserted-by":"crossref","unstructured":"GBD 2017 Stomach Cancer Collaborators. The global, regional, and national burden of stomach cancer in 195 countries, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5:42\u201354.","DOI":"10.1016\/S2468-1253(19)30328-0"},{"key":"13394_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.32074\/1591-951X-166","volume":"112","author":"I Gullo","year":"2020","unstructured":"Gullo I, Grillo F, Mastracci L, Vanoli A, Carneiro F, Saragoni L, Limarzi F, Ferro J, Parente P, Fassan M. Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes. Pathologica. 2020;112:166\u201385.","journal-title":"Pathologica"},{"key":"13394_CR4","first-page":"6735","volume":"52","author":"P Correa","year":"1992","unstructured":"Correa P. Human gastric carcinogenesis: a multistep and multifactorial process\u2013first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735\u201340.","journal-title":"Cancer Res"},{"key":"13394_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-230X-14-21","volume":"14","author":"Y Du","year":"2014","unstructured":"Du Y, Bai Y, Xie P, Fang J, Wang X, Hou X, Tian D, Wang C, Liu Y, Sha W, Wang B, Li Y, Zhang G, Li Y, Shi R, Xu J, Li Y, Huang M, Han S, Liu J, Ren X, Xie P, Wang Z, Cui L, Sheng J, Luo H, Wang Z, Zhao X, Dai N, Nie Y, Zou Y, Xia B, Fan Z, Chen Z, Lin S, Li ZS. Chronic gastritis in China: a national multi-center survey. BMC Gastroenterol. 2014;14:21.","journal-title":"BMC Gastroenterol"},{"key":"13394_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.944494","volume":"12","author":"J Deng","year":"2022","unstructured":"Deng J, Jiang R, Meng E, Wu H. CXCL5: a coachman to drive cancer progression. Front Oncol. 2022;12: 944494.","journal-title":"Front Oncol"},{"key":"13394_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/17474124.2020.1718491","volume":"14","author":"B Annibale","year":"2020","unstructured":"Annibale B, Esposito G, Lahner E. A current clinical overview of atrophic gastritis. Expert Rev Gastroenterol Hepatol. 2020;14:93\u2013102.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"13394_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12876-017-0708-4","volume":"17","author":"AD Spence","year":"2017","unstructured":"Spence AD, Cardwell CR, McMenamin \u00daC, Hicks BM, Johnston BT, Murray LJ, Coleman HG. Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review. BMC Gastroenterol. 2017;17:157.","journal-title":"BMC Gastroenterol"},{"key":"13394_CR9","doi-asserted-by":"publisher","first-page":"942091","DOI":"10.3389\/fonc.2022.942091","volume":"12","author":"L Sun","year":"2022","unstructured":"Sun L, Jin X, Huang L, Zhao J, Jin H, Chen M, Zhang C, Lu B. Risk of progression in patients with chronic atrophic gastritis: a retrospective study. Front Oncol. 2022;12:942091.","journal-title":"Front Oncol"},{"key":"13394_CR10","doi-asserted-by":"publisher","first-page":"e0226427","DOI":"10.1371\/journal.pone.0226427","volume":"14","author":"SY Shin","year":"2019","unstructured":"Shin SY, Kim JH, Chun J, Yoon YH, Park H. Chronic atrophic gastritis and intestinal metaplasia surrounding diffuse-type gastric cancer: are they just bystanders in the process of carcinogenesis? PLoS One. 2019;14:e0226427.","journal-title":"PLoS One"},{"key":"13394_CR11","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1055\/a-1724-7378","volume":"54","author":"R Ortig\u00e3o","year":"2022","unstructured":"Ortig\u00e3o R, Figueir\u00f4a G, Frazzoni L, Pimentel-Nunes P, Hassan C, Dinis-Ribeiro M, Fuccio L, Lib\u00e2nio D. Risk factors for gastric metachronous lesions after endoscopic or surgical resection: a systematic review and meta-analysis. Endoscopy. 2022;54:892\u2013901.","journal-title":"Endoscopy"},{"key":"13394_CR12","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1365-2036.2007.03430.x","volume":"26","author":"MN Weck","year":"2007","unstructured":"Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther. 2007;26:879\u201387.","journal-title":"Aliment Pharmacol Ther"},{"key":"13394_CR13","doi-asserted-by":"publisher","first-page":"912331","DOI":"10.3389\/fmed.2022.912331","volume":"9","author":"B Pei","year":"2022","unstructured":"Pei B, Wen Z, Yang Q, Wang J, Cao Q, Dai L, Li X. Risk factors analysis and prediction model establishment of intestinal metaplasia or dysplasia in patients with chronic atrophic gastritis: a multi-center retrospective study. Front Med. 2022;9:912331.","journal-title":"Front Med"},{"key":"13394_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10654-010-9482-0","volume":"25","author":"MA Adamu","year":"2010","unstructured":"Adamu MA, Weck MN, Gao L, Brenner H. Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies. Eur J Epidemiol. 2010;25:439\u201348.","journal-title":"Eur J Epidemiol"},{"key":"13394_CR15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/apt.14424","volume":"47","author":"YJ Hwang","year":"2018","unstructured":"Hwang YJ, Kim N, Lee HS, Lee JB, Choi YJ, Yoon H, Shin CM, Park YS, Lee DH. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years. Aliment Pharmacol Ther. 2018;47:380\u201390.","journal-title":"Aliment Pharmacol Ther"},{"key":"13394_CR16","doi-asserted-by":"crossref","unstructured":"Baj J, Forma A, Sitarz M, Portincasa P, Garruti G, Krasowska D, Maciejewski R. Helicobacter pylori virulence factors-mechanisms of bacterial pathogenicity in the gastric microenvironment. Cells. 2020;10(1):27.","DOI":"10.3390\/cells10010027"},{"key":"13394_CR17","doi-asserted-by":"publisher","first-page":"e0255601","DOI":"10.1371\/journal.pone.0255601","volume":"16","author":"N Aumpan","year":"2021","unstructured":"Aumpan N, Vilaichone RK, Pornthisarn B, Chonprasertsuk S, Siramolpiwat S, Bhanthumkomol P, Nunanan P, Issariyakulkarn N, Ratana-Amornpin S, Miftahussurur M, Mahachai V, Yamaoka Y. Predictors for regression and progression of intestinal metaplasia (IM): a large population-based study from low prevalence area of gastric cancer (IM-predictor trial). PLoS One. 2021;16:e0255601.","journal-title":"PLoS One"},{"key":"13394_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10120-015-0462-7","volume":"19","author":"HN Chen","year":"2016","unstructured":"Chen HN, Wang Z, Li X, Zhou ZG. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Gastric Cancer. 2016;19:166\u201375.","journal-title":"Gastric Cancer"},{"key":"13394_CR19","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1053\/j.gastro.2020.11.017","volume":"160","author":"MB Piazuelo","year":"2021","unstructured":"Piazuelo MB, Bravo LE, Mera RM, Camargo MC, Bravo JC, Delgado AG, Washington MK, Rosero A, Garcia LS, Realpe JL, Cifuentes SP, Morgan DR, Peek RM Jr, Correa P, Wilson KT. The Colombian chemoprevention trial: 20-year follow-up of a cohort of patients with gastric precancerous lesions. Gastroenterology. 2021;160:1106-1117.e3.","journal-title":"Gastroenterology"},{"key":"13394_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/j.gastro.2022.03.039","volume":"163","author":"L Yan","year":"2022","unstructured":"Yan L, Chen Y, Chen F, Tao T, Hu Z, Wang J, You J, Wong BCY, Chen J, Ye W. Effect of Helicobacter pylori eradication on gastric cancer prevention: updated report from a randomized controlled trial with 26.5 years of follow-up. Gastroenterology. 2022;163:154-162.e3.","journal-title":"Gastroenterology"},{"key":"13394_CR21","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1158\/1055-9965.EPI-12-0202","volume":"21","author":"JS Ren","year":"2012","unstructured":"Ren JS, Kamangar F, Forman D, Islami F. Pickled food and risk of gastric cancer\u2013a systematic review and meta-analysis of English and Chinese literature. Cancer Epidemiol Biomarkers Prevent. 2012;21:905\u201315.","journal-title":"Cancer Epidemiol Biomarkers Prevent"},{"key":"13394_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10654-009-9371-6","volume":"24","author":"AM Asfeldt","year":"2009","unstructured":"Asfeldt AM, Steigen SE, L\u00f8chen ML, Straume B, Johnsen R, Bernersen B, Florholmen J, Paulssen EJ. The natural course of Helicobacter pylori infection on endoscopic findings in a population during 17 years of follow-up: the S\u00f8rreisa gastrointestinal disorder study. Eur J Epidemiol. 2009;24:649\u201358.","journal-title":"Eur J Epidemiol"},{"key":"13394_CR23","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1002\/ijc.24618","volume":"125","author":"L Gao","year":"2009","unstructured":"Gao L, Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Alcohol consumption and chronic atrophic gastritis: population-based study among 9,444 older adults from Germany. Int J Cancer. 2009;125:2918\u201322.","journal-title":"Int J Cancer"},{"key":"13394_CR24","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/oxfordjournals.aje.a010282","volume":"151","author":"T Namekata","year":"2000","unstructured":"Namekata T, Miki K, Kimmey M, Fritsche T, Hughes D, Moore D, Suzuki K. Chronic atrophic gastritis and Helicobacter pylori infection among Japanese americans in Seattle. Am J Epidemiol. 2000;151:820\u201330.","journal-title":"Am J Epidemiol"},{"key":"13394_CR25","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/ijc.25476","volume":"128","author":"MA Adamu","year":"2011","unstructured":"Adamu MA, Weck MN, Rothenbacher D, Brenner H. Incidence and risk factors for the development of chronic atrophic gastritis: five year follow-up of a population-based cohort study. Int J Cancer. 2011;128:1652\u20138.","journal-title":"Int J Cancer"},{"key":"13394_CR26","doi-asserted-by":"publisher","first-page":"e84051","DOI":"10.7554\/eLife.84051","volume":"12","author":"S Yuan","year":"2023","unstructured":"Yuan S, Chen J, Ruan X, Sun Y, Zhang K, Wang X, Li X, Gill D, Burgess S, Giovannucci E, Larsson SC. Smoking, alcohol consumption, and 24 gastrointestinal diseases: Mendelian randomization analysis. eLife. 2023;12:e84051.","journal-title":"eLife"},{"key":"13394_CR27","first-page":"5","volume":"19","author":"KM Chu","year":"2013","unstructured":"Chu KM, Cho CH, Shin VY. Nicotine and gastrointestinal disorders: its role in ulceration and cancer development. Curr Pharm Design. 2013;19:5\u201310.","journal-title":"Curr Pharm Design"},{"key":"13394_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/qjmed\/89.7.485","volume":"89","author":"GA Thomas","year":"1996","unstructured":"Thomas GA, Rhodes J, Green J. Nicotine and gastrointestinal disease. QJM. 1996;89:485\u20138.","journal-title":"QJM"},{"key":"13394_CR29","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.14309\/ajg.0000000000001166","volume":"116","author":"M Laszkowska","year":"2021","unstructured":"Laszkowska M, Rodriguez S, Kim J, Hur C. Heavy alcohol use is Associated with gastric cancer: analysis of the national health and nutrition examination survey from 1999 to 2010. Am J Gastroenterol. 2021;116:1083\u20136.","journal-title":"Am J Gastroenterol"},{"key":"13394_CR30","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1111\/j.1572-0241.2000.03347.x","volume":"95","author":"L Bujanda","year":"2000","unstructured":"Bujanda L. The effects of alcohol consumption upon the gastrointestinal tract. Am J Gastroenterol. 2000;95:3374\u201382.","journal-title":"Am J Gastroenterol"},{"key":"13394_CR31","first-page":"627","volume":"50","author":"A Nomura","year":"1990","unstructured":"Nomura A, Grove JS, Stemmermann GN, Severson RK. A prospective study of stomach cancer and its relation to diet, cigarettes, and alcohol consumption. Cancer Res. 1990;50:627\u201331.","journal-title":"Cancer Res"},{"key":"13394_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12876-021-01794-6","volume":"21","author":"Y Tong","year":"2021","unstructured":"Tong Y, Wang H, Zhao Y, He X, Xu H, Li H, Shuai P, Gong L, Wu H, Xu H, Luo Y, Wang D, Liu S, Song Z. Serum pepsinogen levels in different regions of China and its influencing factors: a multicenter cross-sectional study. BMC Gastroenterol. 2021;21:264.","journal-title":"BMC Gastroenterol"},{"key":"13394_CR33","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/postgradmedj-2020-139183","volume":"98","author":"D Ogutmen Koc","year":"2022","unstructured":"Ogutmen Koc D, Bektas S. Serum pepsinogen levels and OLGA\/OLGIM staging in the assessment of atrophic gastritis types. Postgrad Med J. 2022;98:441\u20135.","journal-title":"Postgrad Med J"},{"key":"13394_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/sjg.sjg_383_22","volume":"29","author":"XK Lin","year":"2023","unstructured":"Lin XK, Wang WL. Analysis of high risk factors for chronic atrophic gastritis. Saudi J Gastroenterol. 2023;29:127\u201334.","journal-title":"Saudi J Gastroenterol"},{"key":"13394_CR35","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/apt.14248","volume":"46","author":"RM Zagari","year":"2017","unstructured":"Zagari RM, Rabitti S, Greenwood DC, Eusebi LH, Vestito A, Bazzoli F. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther. 2017;46:657\u201367.","journal-title":"Aliment Pharmacol Ther"},{"key":"13394_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003599","volume":"95","author":"X Wang","year":"2016","unstructured":"Wang X, Ling L, Li S, Qin G, Cui W, Li X, Ni H. The diagnostic value of gastrin-17 detection in atrophic gastritis: a meta-analysis. Medicine. 2016;95: e3599.","journal-title":"Medicine"},{"key":"13394_CR37","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1038\/s41598-020-61472-7","volume":"10","author":"R Wang","year":"2020","unstructured":"Wang R, Chen XZ. Prevalence of atrophic gastritis in southwest China and predictive strength of serum gastrin-17: a cross-sectional study (SIGES). Sci Rep. 2020;10:4523.","journal-title":"Sci Rep"},{"key":"13394_CR38","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.21037\/jgo-21-254","volume":"12","author":"Z Lin","year":"2021","unstructured":"Lin Z, Bian H, Chen C, Chen W, Li Q. Application of serum pepsinogen and carbohydrate antigen 72\u2009\u2013\u20094 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer. J Gastrointest Oncol. 2021;12:1042\u20138.","journal-title":"J Gastrointest Oncol"},{"key":"13394_CR39","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/ijc.28470","volume":"134","author":"T Yoshida","year":"2014","unstructured":"Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, Oka M, Watanabe M, Enomoto S, Niwa T, Maekita T, Iguchi M, Tamai H, Utsunomiya H, Yamamichi N, Fujishiro M, Iwane M, Takeshita T, Ushijima T, Ichinose M. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer. 2014;134:1445\u201357.","journal-title":"Int J Cancer"},{"key":"13394_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/cac2.12010","volume":"40","author":"W Zhang","year":"2020","unstructured":"Zhang W, Wang H, Sun M, Deng X, Wu X, Ma Y, Li M, Shuoa SM, You Q, Miao L. CXCL5\/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target. Cancer Commun (Lond). 2020;40:69\u201380.","journal-title":"Cancer Commun (Lond)"},{"key":"13394_CR41","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.3892\/or.2017.5942","volume":"38","author":"W Zhang","year":"2017","unstructured":"Zhang W, Gu J, Chen J, Zhang P, Ji R, Qian H, Xu W, Zhang X. Interaction with neutrophils promotes gastric cancer cell migration and invasion by inducing epithelial-mesenchymal transition. Oncol Rep. 2017;38:2959\u201366.","journal-title":"Oncol Rep"},{"key":"13394_CR42","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41419-019-1431-6","volume":"10","author":"C Chen","year":"2019","unstructured":"Chen C, Xu ZQ, Zong YP, Ou BC, Shen XH, Feng H, Zheng MH, Zhao JK, Lu AG. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT\/NF-\u03baB pathway in colorectal cancer. Cell Death Dis. 2019;10:178.","journal-title":"Cell Death Dis"},{"key":"13394_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2018.02.009","volume":"148","author":"D Cui","year":"2018","unstructured":"Cui D, Zhao Y, Xu J. Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of \u03b2-catenin pathway. Biochimie. 2018;148:1\u201311.","journal-title":"Biochimie"},{"key":"13394_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41389-020-00249-z","volume":"9","author":"Z Mao","year":"2020","unstructured":"Mao Z, Zhang J, Shi Y, Li W, Shi H, Ji R, Mao F, Qian H, Xu W, Zhang X. CXCL5 promotes gastric cancer metastasis by inducing epithelial-mesenchymal transition and activating neutrophils. Oncogenesis. 2020;9:63.","journal-title":"Oncogenesis"},{"key":"13394_CR45","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1158\/1078-0432.CCR-18-3567","volume":"25","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Xia G, Xiang Z, Liu M, Wei Z, Yan J, Chen W, Zhu J, Awasthi N, Sun X, Fung KM, He Y, Li M, Zhang C. A C-X-C chemokine receptor type 2-dominated cross-talk between tumor cells and macrophages drives gastric cancer metastasis. Clin Cancer Res. 2019;25:3317\u201328.","journal-title":"Clin Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13394-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13394-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13394-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T11:03:16Z","timestamp":1736506996000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13394-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13394"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13394-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"5 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Second Affiliated Hospital of Anhui University of Chinese Medicine. All participants volunteered to participate in this study and signed the informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}